Open Access<p>The Current Recommended Drugs and Strategies for the Treatment of Coronavirus Disease (COVID-19)</p>
Author(s) -
Mojgan Sheikhpour
Publication year - 2020
Publication title -
therapeutics and clinical risk management
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.719
H-Index - 55
eISSN - 1178-203X
pISSN - 1176-6336
DOI - 10.2147/tcrm.s262936
Subject(s) - medicine , disease , immune system , pharmacology , drug , coronavirus , virology , immunology , infectious disease (medical specialty) , covid-19
The coronavirus 2019 (COVID-19) has been known as a pandemic disease by the World Health Organization (WHO) worldwide. The drugs currently used for treatment of COVID-19 are often selected and tested based on their effectiveness in other diseases such as influenza and AIDS and their major identified targets are viral protease, host cell produced protease, viral RNA polymerase, and the interaction site of viral protein with host cell receptors. Until now, there are no approved therapeutic drugs for definitive treatment of this dangerous disease.